Tapering subcutaneous methotrexate causes more disease flares compared with tapering oral administration in established rheumatoid arthritis patients

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)e216-e218
JournalRheumatology (Oxford, England)
Volume61
Issue number8
DOIs
Publication statusPublished - 1 Aug 2022

Bibliographical note

Funding: This work was supported by ZonMw (grant
number 171102014).

Cite this